Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study
- PMID: 20061435
- DOI: 10.1210/jc.2009-1251
Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study
Abstract
Context: Physical frailty is associated with reduced muscle strength, impaired physical function, and quality of life. Testosterone (T) increases muscle mass and strength in hypogonadal patients. It is unclear whether T has similar effects in intermediate-frail and frail elderly men with low to borderline-low T.
Objective: Our objective was to determine the effects of 6 months T treatment in intermediate-frail and frail elderly men, on muscle mass and strength, physical function, and quality of life.
Design and setting: We conducted a randomized, double-blind, placebo-controlled, parallel-group, single-center study.
Participants: PARTICIPANTS were community-dwelling intermediate-frail and frail elderly men at least 65 yr of age with a total T at or below 12 nmol/liter or free T at or below 250 pmol/liter.
Methods: Two hundred seventy-four participants were randomized to transdermal T (50 mg/d) or placebo gel for 6 months. Outcome measures included muscle strength, lean and fat mass, physical function, and self-reported quality of life.
Results: Isometric knee extension peak torque improved in the T group (vs. placebo at 6 months), adjusted difference was 8.6 (95% confidence interval, 1.3-16.0; P = 0.02) Newton-meters. Lean body mass increased and fat mass decreased significantly in the T group by 1.08 +/- 1.8 and 0.9 +/- 1.6 kg, respectively. Physical function improved among older and frailer men. Somatic and sexual symptom scores decreased with T treatment; adjusted difference was -1.2 (-2.4 to -0.04) and -1.3 (-2.5 to -0.2), respectively.
Conclusions: T treatment in intermediate-frail and frail elderly men with low to borderline-low T for 6 months may prevent age-associated loss of lower limb muscle strength and improve body composition, quality of life, and physical function. Further investigations are warranted to extend these results.
Similar articles
-
Do the effects of testosterone on muscle strength, physical function, body composition, and quality of life persist six months after treatment in intermediate-frail and frail elderly men?J Clin Endocrinol Metab. 2011 Feb;96(2):454-8. doi: 10.1210/jc.2010-1167. Epub 2010 Nov 17. J Clin Endocrinol Metab. 2011. PMID: 21084399 Clinical Trial.
-
A randomized, double-blind, placebo-controlled trial of testosterone gel on body composition and health-related quality-of-life in men with hypogonadal to low-normal levels of serum testosterone and symptoms of androgen deficiency over 6 months with 12 months open-label follow-up.Aging Male. 2012 Dec;15(4):198-207. doi: 10.3109/13685538.2012.699562. Epub 2012 Jul 26. Aging Male. 2012. PMID: 22834649 Clinical Trial.
-
The effects of growth hormone and/or testosterone in healthy elderly men: a randomized controlled trial.J Clin Endocrinol Metab. 2006 Feb;91(2):477-84. doi: 10.1210/jc.2005-0957. Epub 2005 Dec 6. J Clin Endocrinol Metab. 2006. PMID: 16332938 Clinical Trial.
-
Testosterone, frailty and physical function in older men.Expert Rev Endocrinol Metab. 2018 May;13(3):159-165. doi: 10.1080/17446651.2018.1475227. Epub 2018 May 16. Expert Rev Endocrinol Metab. 2018. PMID: 30058896 Review.
-
Testosterone Deficiency and Testosterone Treatment in Older Men.Gerontology. 2017;63(2):144-156. doi: 10.1159/000452499. Epub 2016 Nov 18. Gerontology. 2017. PMID: 27855417 Review.
Cited by
-
Metabolic complications of hepatitis C virus infection.World J Gastroenterol. 2021 Apr 7;27(13):1267-1282. doi: 10.3748/wjg.v27.i13.1267. World J Gastroenterol. 2021. PMID: 33833481 Free PMC article. Review.
-
Testosterone Treatment and Sexual Function in Older Men With Low Testosterone Levels.J Clin Endocrinol Metab. 2016 Aug;101(8):3096-104. doi: 10.1210/jc.2016-1645. Epub 2016 Jun 29. J Clin Endocrinol Metab. 2016. PMID: 27355400 Free PMC article. Clinical Trial.
-
Aging and declining testosterone: past, present, and hopes for the future.J Androl. 2012 Nov-Dec;33(6):1111-8. doi: 10.2164/jandrol.112.017160. Epub 2012 Aug 9. J Androl. 2012. PMID: 22879528 Free PMC article. Review.
-
The safety, pharmacokinetics, and effects of LGD-4033, a novel nonsteroidal oral, selective androgen receptor modulator, in healthy young men.J Gerontol A Biol Sci Med Sci. 2013 Jan;68(1):87-95. doi: 10.1093/gerona/gls078. Epub 2012 Mar 28. J Gerontol A Biol Sci Med Sci. 2013. PMID: 22459616 Free PMC article. Clinical Trial.
-
A simple frailty questionnaire (FRAIL) predicts outcomes in middle aged African Americans.J Nutr Health Aging. 2012 Jul;16(7):601-8. doi: 10.1007/s12603-012-0084-2. J Nutr Health Aging. 2012. PMID: 22836700 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical